These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 3930326)

  • 1. Activation of aldose reductase from human tissues.
    Das B; Srivastava SK
    Diabetes; 1985 Nov; 34(11):1145-51. PubMed ID: 3930326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase.
    Srivastava SK; Ansari NH; Hair GA; Awasthi S; Das B
    Metabolism; 1986 Apr; 35(4 Suppl 1):114-8. PubMed ID: 3083202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties.
    Srivastava SK; Ansari NH; Hair GA; Jaspan J; Rao MB; Das B
    Biochim Biophys Acta; 1986 Mar; 870(2):302-11. PubMed ID: 3082363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil.
    O'Brien MM; Schofield PJ; Edwards MR
    J Neurochem; 1982 Sep; 39(3):810-4. PubMed ID: 6808090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of aldose reductase inhibitors in vitro. Effects of enzyme purification and substrate type.
    Poulsom R
    Biochem Pharmacol; 1987 May; 36(10):1577-81. PubMed ID: 3109423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM; Sochor M; Hothersall JS; McLean P
    Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors.
    Srivastava SK; Petrash JM; Sadana IJ; Ansari NH; Partridge CA
    Curr Eye Res; 1982-1983; 2(6):407-10. PubMed ID: 6820339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM; González RG
    Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S; Das B; Srivastava SK
    Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of aldose reductase by nonenzymatic glycosylation.
    Srivastava SK; Ansari NH; Bhatnagar A; Hair G; Liu S; Das B
    Prog Clin Biol Res; 1989; 304():171-84. PubMed ID: 2506561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde and aldose reductases from human placenta. Heterogeneous expression of multiple enzyme forms.
    Vander Jagt DL; Hunsaker LA; Robinson B; Stangebye LA; Deck LM
    J Biol Chem; 1990 Jul; 265(19):10912-8. PubMed ID: 2113526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine lens aldehyde reductase (aldose reductase). Purification, kinetics and mechanism.
    Halder AB; Crabbe MJ
    Biochem J; 1984 Apr; 219(1):33-9. PubMed ID: 6426471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE; Lai CJ
    Arch Biochem Biophys; 1996 Mar; 327(1):89-97. PubMed ID: 8615700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NADPH-dependent reductases of the dog lens.
    Sato S; Kador PF
    Exp Eye Res; 1990 Jun; 50(6):629-34. PubMed ID: 2115452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine lens aldose reductase: identification of two enzyme forms.
    Del Corso A; Barsacchi D; Camici M; Garland D; Mura U
    Arch Biochem Biophys; 1989 May; 270(2):604-10. PubMed ID: 2495769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of aldose reductase and aldehyde reductase II from human erythrocyte.
    Das B; Srivastava SK
    Arch Biochem Biophys; 1985 May; 238(2):670-9. PubMed ID: 3922304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid.
    Ou P; Nourooz-Zadeh J; Tritschler HJ; Wolff S
    Free Radic Res; 1996 Oct; 25(4):337-46. PubMed ID: 8889497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIH conference. Aldose reductase and complications of diabetes.
    Cogan DG; Kinoshita JH; Kador PF; Robison G; Datilis MB; Cobo LM; Kupfer C
    Ann Intern Med; 1984 Jul; 101(1):82-91. PubMed ID: 6203454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.